Inhalation Anesthesia Market Worth $1.50 Billion By 2022: Grand View Research, Inc.

SAN FRANCISCO, September 8, 2015 /PRNewswire/ --

Global Inhalation anesthesia market is expected to reach USD 1.50 billion by 2022, according to a new study by Grand View Research Inc. Inhalation anesthesia market is expected to witness lucrative growth over the forecast period.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757 )

Key factors attributing to its rapid growth include increasing geriatric population prone to chronic diseases such as cardiovascular, respiratory, cancer, neurological and other health ailments such as gastro, orthopedic and spinal problems.

Increasing number of emergency cases and growing demand for short stay ambulatory day care surgical procedure are amongst critical success factors accounting for rapid market growth.

Browse full research report with TOC on "Inhalation Anesthesia Market Analysis By Product (Sevoflurane, Isoflurane, Desflurane), By Application (Induction, Maintenance) And Segment Forecasts To 2022" at: http://www.grandviewresearch.com/industry-analysis/inhalation-anesthesia-market            

Growing penetration of universal health insurance coverage to wider population and constant improvements in healthcare infrastructure in various developing countries are expected to positively impact the number of surgeries performed thus, increasing the usage rates of inhalation anesthetics over the next seven years.

The inhalation anesthesia market comprises products such as sevoflurane, isoflurane and desflurane. These are used for induction and maintenance of anesthesia for patients during surgical procedures.

Further key findings from the study suggest: 

• Sevoflurane market was the largest product group, accounting for over 70.0% demand in 2014, owing to its therapeutic advantages, low cost and higher potency for the induction of anesthesia. However, isoflurane is expected to witness lucrative growth of nearly 12.0% over the forecast period owing to its usage in the maintenance of anesthesia.
• In 2014, North America inhalation anesthesia market accounted for nearly 43.0% of the total revenue. Key factors accounting for its large share include increasing prevalence of chronic diseases and geriatric population and presence of advanced healthcare facilities in the region.
• Asia Pacific is identified as the fastest growing regional market. The increasing public and private healthcare expenditure and demand for medical tourism are some primary growth contributing factors.
• The market is dominated by players such as Abbvie and Baxter. Emerging players such as Piramal Healthcare, Hikma, Lunan Pharmaceuticals are expected to intensify the generic competition and play a significant role in shaping the market dynamics.
• The anesthesia recycling market is likely to gain momentum over the forecast period, due to, heightening environmental concerns. Currently, anesthesia recycling systems are developed by two companies namely Anesthesia reclamation LLC, and Deltasorb Technologies (Blue Zone Technology)

Grand View Research has segmented the inhalation anesthesia market on the basis of the following procedures:

• Global Inhalation Anesthesia Market, Product Outlook (Revenue, USD Million, 2012 - 2022) 
  • Sevoflurane
  • Isoflurane
  • Desflurane
• Global Inhalation Anesthesia Market, Application Outlook (Revenue, USD Million, 2012 - 2022) 
  • Induction
  • Maintenance
• Global Inhalation Anesthesia Market, Regional Outlook (Revenue, USD Million) 2012 - 2022) 
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Australia
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa

Browse related reports by Grand View Research: 

• Cancer Immunotherapy Market - http://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-market  

• Brain Tumor Diagnosis And Therapeutics Market - http://www.grandviewresearch.com/industry-analysis/brain-tumor-diagnosis-and-therapeutics-market  

• Pediatric Vaccine Market - http://www.grandviewresearch.com/industry-analysis/pediatric-vaccine-market  

• Body Contouring Devices Market - http://www.grandviewresearch.com/industry-analysis/body-contourin-devices-market                                                                                                  

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs - esorics2010.org, apavirginia.org, terrapass.org  

Contact: 

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: [email protected]

Web: www.grandviewresearch.com  

SOURCE Grand View Research, Inc.